Nephros (NEPH) Current Leases (2019 - 2020)
Nephros' (NEPH) quarterly Current Leases came in at $332000.0 in Q4 2020, up 26.72% year-on-year from $262000.0 in Q1 2020, and up 1.84% quarter-over-quarter from $326000.0 in Q3 2020.
Nephros (NEPH) Current Leases (2019 - 2020) Analysis & Trends
Nephros' Current Leases history runs 2 years deep, the most recent figure standing at $332000.0 for Q4 2020.
- On a quarterly basis, Current Leases rose 26.72% year-over-year to $332000.0 in Q4 2020; TTM through Dec 2020 was $332000.0, a 26.72% increase from a year earlier, with the FY2020 full-year figure at $332000.0, up 26.72% from the prior year.
- Current Leases grew to $332000.0 in Q4 2020 per NEPH's latest filing, from $326000.0 in the prior quarter.
- Across five years, Current Leases topped out at $332000.0 in Q4 2020 and bottomed at $191000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 29.23 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 20.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 332,000.00 |
| Sep 30, 2020 | 326,000.00 |
| Jun 30, 2020 | 315,000.00 |
| Mar 31, 2020 | 312,000.00 |
| Dec 31, 2019 | 262,000.00 |
| Sep 30, 2019 | 251,000.00 |
| Jun 30, 2019 | 223,000.00 |
| Mar 31, 2019 | 191,000.00 |